Robert Goodwin

1.8k total citations · 1 hit paper
26 papers, 1.2k citations indexed

About

Robert Goodwin is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Goodwin has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Goodwin's work include Fungal Infections and Studies (7 papers), Antifungal resistance and susceptibility (6 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Robert Goodwin is often cited by papers focused on Fungal Infections and Studies (7 papers), Antifungal resistance and susceptibility (6 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Robert Goodwin collaborates with scholars based in United States, Australia and Canada. Robert Goodwin's co-authors include Roger M. Des Prez, Robert H. Alford, James D. Snell, Richard D. Buchanan, Cynthia Padula, Ross C. Kory, George R. Meneely, Peter C.Y. Chow, Jessica Yin and Barry J. Marshall and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Robert Goodwin

22 papers receiving 1.0k citations

Hit Papers

Disseminated Histoplasmosis 1980 2026 1995 2010 1980 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Goodwin United States 12 773 605 228 190 101 26 1.2k
A.B.M. Foot United Kingdom 20 364 0.5× 216 0.4× 146 0.6× 128 0.7× 86 0.9× 34 1.2k
J.C.M. Shastry India 19 348 0.5× 352 0.6× 102 0.4× 174 0.9× 76 0.8× 64 964
Monica Grazziutti United States 21 641 0.8× 646 1.1× 156 0.7× 82 0.4× 35 0.3× 37 1.3k
Lorrie Lucht United States 16 663 0.9× 351 0.6× 298 1.3× 61 0.3× 63 0.6× 27 1.1k
Karolyn A. Wanat United States 20 437 0.6× 213 0.4× 143 0.6× 102 0.5× 92 0.9× 144 1.3k
C Cordonnier France 14 431 0.6× 270 0.4× 195 0.9× 67 0.4× 45 0.4× 33 796
Rocío Parody Spain 21 723 0.9× 447 0.7× 100 0.4× 159 0.8× 106 1.0× 52 1.4k
Yury Monczak Canada 11 1.1k 1.4× 1.5k 2.5× 83 0.4× 327 1.7× 45 0.4× 15 2.1k
Yutaka Sugita Japan 19 755 1.0× 482 0.8× 1.1k 4.8× 267 1.4× 57 0.6× 132 1.9k
V. Boussaud France 18 305 0.4× 298 0.5× 312 1.4× 230 1.2× 56 0.6× 46 822

Countries citing papers authored by Robert Goodwin

Since Specialization
Citations

This map shows the geographic impact of Robert Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Goodwin more than expected).

Fields of papers citing papers by Robert Goodwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Goodwin. The network helps show where Robert Goodwin may publish in the future.

Co-authorship network of co-authors of Robert Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Goodwin. A scholar is included among the top collaborators of Robert Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Goodwin. Robert Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Viswambaram, Pravin, et al.. (2023). Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for intravesical bacillus Calmette–Guerin. Asia-Pacific Journal of Clinical Oncology. 19(6). 697–705.
3.
Marshall, Barry J., et al.. (2019). <p>Structural, biomechanical and hemodynamic assessment of the bladder wall in healthy subjects</p>. Research and Reports in Urology. Volume 11. 233–245. 10 indexed citations
4.
Weickhardt, Andrew, Farshad Foroudi, Shomik Sengupta, et al.. (2018). Pembrolizumab and chemoradiotherapy for muscle invasive bladder cancer: The ANZUP 1502 PCR-MIB trial.. Journal of Clinical Oncology. 36(6_suppl). TPS531–TPS531. 3 indexed citations
5.
Padula, Cynthia, et al.. (2017). Prevention of Medical Device–Related Pressure Injuries Associated With Respiratory Equipment Use in a Critical Care Unit. Journal of Wound Ostomy and Continence Nursing. 44(2). 138–141. 32 indexed citations
6.
Perez, Raymond P., Patrick Archdeacon, Nancy Roach, et al.. (2017). Sponsors’ and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials. Clinical Trials. 14(3). 225–233. 6 indexed citations
7.
Goodwin, Robert & James D. Snell. (2015). The Enlarging Histoplasmoma. American Review of Respiratory Disease.
8.
Goodwin, Robert, et al.. (2010). Investigation on the antimicrobial effect of ammonyx on some pathogenic microbes observed on sweatshirt sport. World academy of science, engineering and technology. 64. 8–11. 18 indexed citations
9.
Goodwin, Robert, et al.. (2010). Application of multinomial (MN) phase II designs in trials of targeted agents.. Journal of Clinical Oncology. 28(15_suppl). 3074–3074. 2 indexed citations
11.
Schlesinger, Zwi, et al.. (1986). Community Phase of Cardiac Rehabilitation. Advances in cardiology. 33. 178–189. 1 indexed citations
12.
Goodwin, Robert, et al.. (1981). Histoplasmosis of bone. The American Journal of Medicine. 70(4). 864–866. 21 indexed citations
13.
Goodwin, Robert, et al.. (1981). Histoplasmosis in Normal Hosts. Medicine. 60(4). 231–266. 200 indexed citations
14.
Goodwin, Robert, et al.. (1980). Histoplasmosis with Symptomatic Lymphadenopathy. CHEST Journal. 77(2). 213–215. 9 indexed citations
15.
Goodwin, Robert, et al.. (1980). Disseminated Histoplasmosis. Medicine. 59(1). 1–33. 429 indexed citations breakdown →
16.
Goodwin, Robert, et al.. (1976). Pulmonary Vein Obstruction by Bronchogenic Carcinoma. Southern Medical Journal. 69(11). 1482–1483. 5 indexed citations
17.
Alford, Robert H. & Robert Goodwin. (1972). Patterns of Immune Response in Chronic Pulmonary Histoplasmosis. The Journal of Infectious Diseases. 125(3). 269–275. 20 indexed citations
18.
Goodwin, Robert, et al.. (1972). MEDIASTINAL FIBROSIS COMPLICATING HEALED PRIMARY HISTOPLASMOSIS AND TUBERCULOSIS. Medicine. 51(3). 227–246. 150 indexed citations
19.
Kory, Ross C., et al.. (1953). Pulmonary Function and Circulatory Dynamics in Artificial Pneumoperitoneum. Diseases of the Chest. 23(6). 608–620. 9 indexed citations
20.
Kory, Ross C., et al.. (1953). Pulmonary Function and Circulatory Dynamics in Artificial Pneumoperitoneum. Diseases of the Chest. 23(6). 595–607. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026